UroLift® vs Other Treatment Options

The UroLift® System is a proven option for patients looking for an alternative to drugs or major surgery. It is the only BPH treatment that does not require ongoing medication, heating, cutting or removal of the prostate tissue.

The UroLift® System offers a proven treatment with minimal risk of side effects while preserving sexual function*1.

What Are the Treatment Options?

  • Non-Invasive

    Medication & Monitoring

    Alpha-blockers can help relax the muscles around the neck of the bladder to aid urination, while alpha-reductase inhibitors can help to shrink the prostate.

    Patients need to continue taking medication to manage their condition, which may lead to common side effects including dizziness, fatigue, and sexual dysfunction.2,3

  • Minimally Invasive

    Prostatic Urethral Lift (PUL) – Using the UroLift® System

    A straightforward procedure that deploys small implants to lift and compress the sides of the prostate to make the urethra wider and increase the flow of urine.

    As PUL does not remove or damage prostate tissue, it can better preserve sexual function compared to other procedures. Side effects are mild to moderate and transient, e.g., urgency to urinate, pain with urination, and pelvic discomfort.1,3

  • Thermotherapies & Lasers

    An array of semi-invasive procedures involving the removal of prostate tissue via heat, steam, or lasers to relieve symptoms.

    Patients often need to have a catheter inserted into their bladder during the recovery process.

    In addition to side effects involving urgency to urinate and pain with urination, these procedures also have incidences of erectile and/or ejaculatory dysfunction.2,3

  • Most Invasive


    Transurethral resection of the prostate (TURP) involves using a superheated thin metal band to cut and remove prostate tissue. In severe cases with very large prostate or complications, open surgery is needed to reach the prostate.

    Surgery requires recovery in the hospital with a catheter inserted into the bladder. Surgery also has higher incidences of bleeding, erectile and/or ejaculatory dysfunction.3

Preservation of Sexual Function

The UroLift® System Treatment:
The only leading BPH procedure shown not to cause new and lasting sexual dysfunction*2,4,5

In a global survey of over 13,000 men aged 40-80 across 29 countries, nearly 50% rated sex as being very to extremely important.6 Erectile dysfunction contributes to anxiety, depression, loss of self-esteem and diminished quality of life.7 In choosing a BPH treatment, it is important to consider the impact that ejaculatory and erectile dysfunction have on patient satisfaction.

Low Retreatment Rate

The rate of surgical intervention for failure to cure with the UroLift® System remains low for a BPH procedure, with approximately 13.6% over five years or about 2-3% per year.1 Over the first postoperative year, no additional surgical intervention was required for bladder neck contracture, bleeding, or stress incontinence in the pivotal study on UroLift® System.4

*No instances of new onset, sustained erectile or ejaculatory dysfunction in the LIFT pivotal study



Roehrborn et al. Can J Urol 2017


AUA Guidelines 2003


Mayo Clinic, Patient Care & Health Information, Diseases & Conditions, Benign prostatic hyperplasia (BPH). Accessed 1 Dec 2021


Roehrborn, J Urology 2013


McVary, J Urol 2016


Laumann, Arch Sex Beh April 2006


Carbone, Int J Impot Res 2003

Healthcare Professional Confirmation

The information on the page you are about to enter is intended for Healthcare Professionals only.
By clicking the box below, you confirm that you are a Healthcare Professional.